Friday’s opening race at York is a competitive mile handicap at 1.50pm, with a strong field of unexposed three-year-olds set to make it a fascinating contest. Among the most interesting runners is
More
Aurinia Pharmaceuticals (AUPH) has reached a patent infringement settlement with Teva Pharmaceuticals (TEVA) over its flagship lupus drug Lupkynis (voclosporin). The deal should prevent Teva from launching a generic version of voclosporin
More
Customer satisfaction across the pharmacy sector is splitting sharply, with mail-order services rising while traditional retail pharmacies struggle to retain consumer confidence. The findings come from the J.D. Power 2026 U.S. Pharmacy
More
British American Tobacco (BTI) serves as a stark warning that resolving enforcement actions with US authorities does not close the door on further legal exposure worldwide. Most corporations operating globally consider government
More
The United States is treating tokenization less as a speculative phenomenon and more as a fundamental redesign of how financial infrastructure operates at scale. Recent moves by U.S. regulators signal a shift
More
Legal World Buzzes With Biglaw Hiring Rows, A Tupac Murder Trial, And A Drunk Official At McDonald’s
Biglaw firms are facing significant backlash over their push to recruit first-year law students at an extraordinarily early stage in their legal education. A judge has had their law license suspended after
More
Coty Inc (COTY) is among a group of notable stocks trading lower in Thursday’s pre-market session following a mixed set of fourth-quarter results. The beauty and fragrance company’s latest quarterly figures failed
More
The North American Income Trust, trading on the London Stock Exchange under the ticker NAIT, has been added to the FTSE 250 Index, marking a significant milestone for the investment trust. Inclusion
More
Amazon has confirmed it buys books through commercial channels after an investigation linked a bulk order of rare books to a facility where physical copies are reportedly destroyed and scanned. “Amazon purchases
More
Ultragenyx Pharmaceutical (RARE) has earned its first FDA approval in gene therapy, landing an accelerated green light for its treatment targeting glycogen storage disease type Ia. The FDA approved pariglasgene brecaparvovec-opnr, previously
More